Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2022Pharmacognosy JournalOpen Access

In Silico Screening of Bioactive Compounds from Syzygium cumini L. and Moringa oleifera L. Against SARS-CoV-2 via Tetra Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

NANur Sofiatul AiniVKViol Dhea KharismaMWMuhammad Hermawan Widyananda

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aini et al. (2022) studied this question.

synapsesocial.com/papers/6ab7809eaed41efa91939d14https://doi.org/10.5530/pj.2022.14.95
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography2020 · 490 citations
  2. 2Tea catechin as antiviral agent via apoptosis agonist and triple inhibitor mechanism against HIV-1 infection: A bioinformatics approach2021 · 51 citations
  3. 3Computational Drug Design Study of Curcuma longa L. Compound as HPV-16 Antiviral Candidate Against Cervical Cancer2022 · 16 citations
  4. 4COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein2021 · 81 citations